Last reviewed · How we verify

NCT06689579

Unipolar vs Bipolar Hemiarthroplasty for Hip Fracture

Completed Phase 4 Last updated 14 November 2024
What this trial tests

Phase 4 trial testing Unipolar hemiarthroplasty in Hip Fractures in 400 participants. Completed in 26 June 2019.

Timeline
14 October 2014
Primary endpoint
26 June 2019
26 June 2019

Quick facts

Lead sponsorNHS Lothian
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment400
Start date14 October 2014
Primary completion26 June 2019
Estimated completion26 June 2019
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

NHS Lothian — full company profile →

Who can join

Eligibility, any sex, with Hip Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether significant functional benefits are seen in patients who have a bipolar hemiarthroplasty as treatment for hip fracture compared to those who have a unipolar hemiarthroplasty.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hip Fractures

Currently open trials in the same condition.

Other NHS Lothian trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06689579.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing